# PK/PD of EA-230 During Endotoxemia

> **NCT02629874** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Endotoxemia
- Systemic Inflammatory Response

## Interventions

- **DRUG:** EA-230
- **DRUG:** Endotoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02629874
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629874, "PK/PD of EA-230 During Endotoxemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02629874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*